IOL Chemicals and Pharmaceuticals Limited Stock

Equities

IOLCP

INE485C01011

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:55 2024-07-19 EDT 5-day change 1st Jan Change
403.2 INR -2.25% Intraday chart for IOL Chemicals and Pharmaceuticals Limited -4.09% -12.97%

Financials

Sales 2024 21.33B 255M 350M Sales 2025 * 25.02B 299M 411M Capitalization 23.62B 282M 388M
Net income 2024 1.34B 16.06M 22.06M Net income 2025 * 1.93B 23.08M 31.69M EV / Sales 2024 1 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.94 x
P/E ratio 2024
15.8 x
P/E ratio 2025 *
12.3 x
Employees 2,569
Yield 2024 *
1.58%
Yield 2025 *
1.69%
Free-Float 37.75%
More Fundamentals * Estimated data
Dynamic Chart
IOL Chemicals Gets Chinese Regulator's Nod to Export Fenofibrate to China; Shares Up 7% MT
IOL Chemicals and Pharmaceuticals Limited Announces National Medical Products Administration, China Approves Fenofibrate CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q4 2024 Earnings Call, May 16, 2024
IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units MT
IOL Chemicals Gets Nod to Export Diabetes Drug to China MT
IOL Chemicals and Pharmaceuticals Limited Announces CDE, China Approved Metformin Hydrochloride CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 08, 2024
IOL Chemicals and Pharmaceuticals Limited Approves Closing of M/S Iol Global Limited, Uk, Wholly Owned Subsidiary of the Company CI
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Financial Year 2023-24 CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 09, 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q1 2024 Earnings Call, Aug 16, 2023
CARE Keeps A+ Rating on IOL Chemicals' Long-term Bank Financing; Outlook Stable MT
IOL Chemicals Opens New Acetic Anhydride Facility MT
More news

Latest transcript on IOL Chemicals and Pharmaceuticals Limited

1 day-2.25%
1 week-4.09%
Current month-0.12%
1 month-2.34%
3 months+3.58%
6 months-10.40%
Current year-12.97%
More quotes
1 week
401.95
Extreme 401.95
430.00
1 month
400.05
Extreme 400.05
449.05
Current year
333.00
Extreme 333
497.60
1 year
333.00
Extreme 333
535.60
3 years
272.20
Extreme 272.2
715.30
5 years
147.35
Extreme 147.35
898.40
10 years
24.50
Extreme 24.5
898.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-04-02
Director of Finance/CFO - -
Compliance Officer - 19-11-13
Members of the board TitleAgeSince
Chairman 71 19-02-05
Director/Board Member 61 07-08-31
Director/Board Member - 14-08-21
More insiders
Date Price Change Volume
24-07-19 403.2 -2.25% 31 026
24-07-18 412.4 -1.23% 10,881
24-07-16 417.6 -0.78% 38,978
24-07-15 420.9 -1.67% 7,176
24-07-12 428 +1.83% 30,423

Delayed Quote Bombay S.E., July 19, 2024 at 06:00 am

More quotes
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical, and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) include Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin. Its Specialty Chemical division includes Ethyl Acetate, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and paint industry.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
403.2 INR
Average target price
471 INR
Spread / Average Target
+16.83%
Consensus

Quarterly revenue - Rate of surprise